Get started
Author

Г. Н. Енгалычева

Observed names: G ENGALYCHEVA, G N Engalycheva, G, N. Engalycheva, G. N. ENGALYCHEVA, G. N. Engalycheva, G.N. Yengalycheva, Galina N. Engalycheva, Г Н Енгалычева, Г.Н. Енгалычева, Енгалычева Г. Н., Енгалычева Г.Н., Енгалычева Галина Нинелевна
ORCID: 0000-0001-5121-0858
Observed ORCID: 0000-0001-5121-0858
OpenAlex ID: A5068915467
Development of Paediatric Medicines: Key Risk Factors and Non-clinical Research Programmes
2023 · G. N. Engalycheva, R. D. Syubaev · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 36
PDF
N-nitropyrazoles: A new class of nitrogen oxide generators
1998 · N. B. Grigor'ev, M. I. Kalinkina, et al. · Pharmaceutical Chemistry Journal · 10
Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies
2020 · O, A. Bezborodova, A. A. Pankratov, et al. · Ведомости Научного центра экспертизы средств медицинского применения · 7
PDF
Safety Pharmacology Studies of Medicinal Products: Evaluation of Results
2018 · G. N. Engalycheva, R. D. Syubaev, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 7
Relevant Species Selection for Preclinical Safety Studies of Medicines: A Review
2025 · G. N. Engalycheva, R. D. Syubaev · Safety and Risk of Pharmacotherapy · 6
PDF
Quality Standards of Preclinical Pharmacological Studies
2019 · G, N. Engalycheva, R. D, Syubaev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 6
WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
2024 · G. N. Engalycheva, R. D. Syubaev · Safety and Risk of Pharmacotherapy · 5
PDF
Mathematical Prediction of the Efficacy of Medicinal Products in Preclinical Studies
2022 · O. V. Shreder, N. D. Bunyatyan, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 5
PDF
High Dose Selection for General Toxicity Studies of New Medicines
2023 · G. N. Engalycheva, R. D. Subaev · Safety and Risk of Pharmacotherapy · 4
PDF
Expert Evaluation of Preclinical Toxicokinetic Studies of Pharmaceuticals (Review)
2018 · R. D. Syubaev, G. N. Engalycheva, et al. · Pharmaceutical Chemistry Journal · 4
Дизайн фармакологического эксперимента. Внедрение принципов ARRIVE в работу исследовательских центров
2022 · Ю.Р. Болсуновская, Г.Н. Енгалычева, et al. · 3
β-Mercaptoguanidine derivatives – new class of potential NO-generating compounds
1996 · Vladimir G. Granik, Nikita B. Grigoriev, et al. · Mendeleev Communications · 3
Mechanisms of the vasodilator effect of nitroglycerin and chlorpromazine and specificities of their interaction in a model of isolated rat thoracic aorta
1994 · A. S. Dukhanin, V. Yu. Shilo, et al. · Bulletin of Experimental Biology and Medicine · 2
Synthesis and antiallergic activity of 7-substituted theophylline derivatives
1989 · R. G. Glushkov, I. M. Ovcharova, et al. · Pharmaceutical Chemistry Journal · 2
Preparation of a Nonclinical Overview Based on Scientific Literature
2021 · G. N. Engalycheva, R. D. Syubaev · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 1
Экспертная оценка доклинических исследований токсикокинетики лекарственных средств (обзор)
2018 · Рашид Даутович Сюбаев, Г. Н. Енгалычева, et al. · Химико-фармацевтический журнал · 1
PDF
Expert Evaluation of Preclinical Studies of Primary and Secondary Pharmacodynamics of Medicines
2018 · G. N. Engalycheva, R. D. Subaev, et al. · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 1
PDF
Synthesis and pharmacological activity of 21-esters of prednisolone with glycine and glutamic acid
1991 · M. I. Ryakhovskaya, G. S. Grinenko, et al. · Pharmaceutical Chemistry Journal · 1
Oligonucleotide-based medicinal products: A review of current regulatory requirements for preclinical studies
2026 · G. N. Engalycheva, R. D. Syubaev, et al. · Biological Products Prevention Diagnosis Treatment
PDF
Preclinical Studies of Modern Radiopharmaceuticals: Expert Approaches to Evaluating the Results
2025 · G. N. Engalycheva, R. D. Syubaev, et al. · Safety and Risk of Pharmacotherapy
Predicting the Relative Risk of Pharmacotherapy Based on a Mathematical Model of Age-Related Decline in Homeostasis in Elderly and Senile Patients
2025 · R. D. Syubaev, G. N. Engalycheva · Safety and Risk of Pharmacotherapy
Preclinical safety studies of medicines in the Eurasian economic union
2025 · G. N. Engalycheva, R. D. Syubaev, et al. · Pharmacokinetics and Pharmacodynamics
PDF
Osobennosti Podgotovki Programmy Issledovanij Biologicheskih Lekarstvennyh Sredstv
2023 · K KRYSHEN, A BERCHATOVA, et al.
Лаборатории в испытательных центрах
2021 · Ю.Р. Болсуновская, Я.А. Гущин, et al.
Justification of Safety of Homeopathic Medicines in a Registration Dossier
2019 · R. D. Subaev, G. N. Engalycheva, et al. · Safety and Risk of Pharmacotherapy
PDF
Works count: 56
Citation count: 104
H-index: 6
I10-index: 2
Year
Topic
Type